- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cedara wins some, loses some
Toronto-based Cedara introduced a new orthopedics desk application July 16. Earlier in the month, the company announced a deal with a major Chinese OEM to supply a user interface for its x-ray products. The good news came, however, on the heels of an
Toronto-based Cedara introduced a new orthopedics desk application July 16. Earlier in the month, the company announced a deal with a major Chinese OEM to supply a user interface for its x-ray products. The good news came, however, on the heels of an announcement that the company has been delisted from the Nasdaq effective July 7.
The newly released Cedara OrthoWorks is a suite of desktop and Web server software solutions designed for orthopedic surgeons. The product allows instant access to digital patient images, surgical planning aids, measurement tools, and a library of digital prosthetic templates.
The product release followed a July 7 announcement that Shan Dong XinHua Medical, one of the largest medical equipment manufacturers in China, will integrate its new x-ray systems with Cedara's I-Acquire DR universal acquisition console application. The Cedara technology allows the acquisition of images from multiple digital detectors and x-ray generators from a single user interface.
Cedara stock is now being traded on the OTC Bulletin Board in the wake of its delisting from the Nasdaq. The move became necessary when Cedara was not able to meet the minimum shareholders' equity requirement. The company's listing on the Toronto Stock Exchange, where most of its shares have historically traded, was not affected.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
